Duopharma Biotech Berhad (KLSE:DPHARMA)
1.290
+0.010 (0.78%)
At close: May 19, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.24 billion as of May 19, 2026. Its market cap has increased by 7.50% in one year.
Market Cap
1.24B
Enterprise Value
1.45B
Revenue
916.83M
Ranking
n/a
PE Ratio
13.42
Stock Price
1.29
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.24B, an increase of 563.59%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.24B | 3.20% |
| Dec 31, 2025 | 1.20B | - |
| Dec 31, 2024 | 1.20B | -0.79% |
| Dec 29, 2023 | 1.21B | -20.94% |
| Dec 30, 2022 | 1.53B | -3.10% |
| Dec 31, 2021 | 1.58B | -33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cahya Mata Sarawak Berhad | 1.28B |
| Mega Fortris Berhad | 1.25B |
| HI Mobility Berhad | 1.25B |
| Lagenda Properties Berhad | 1.25B |
| Berjaya Property Berhad | 1.25B |
| United Malacca Berhad | 1.24B |
| NCT Alliance Berhad | 1.24B |
| Dagang NeXchange Berhad | 1.23B |